apigenin has been researched along with Erythema* in 2 studies
2 trial(s) available for apigenin and Erythema
Article | Year |
---|---|
Proof of efficacy of Kamillosan(R) cream in atopic eczema.
Kamillosan(R) cream contains chamomile extract as active principle manufactured from the chamomile sort Manzana which is rich in active principles and has been proved not to exhibit a chamomile-related allergen potential. For this reason Kamillosan(R) cream is suited for local therapy of atopic eczema. In a partially double-blind, randomized study carried out as a half-side comparison, Kamillosan(R) cream was tested vs. 0.5% hydrocortisone cream and the vehicle cream as placebo in patients suffering from medium-degree atopic eczema. After a 2-week treatment Kamillosan(R) cream showed a mild superiority towards 0.5% hydrocortisone and a marginal difference as compared to placebo. Topics: Administration, Topical; Anti-Inflammatory Agents; Arachidonic Acid; Arm; Chamomile; Dermatitis, Atopic; Drug Combinations; Erythema; Humans; Hydrocortisone; Middle Aged; Oils, Volatile; Phytotherapy; Plant Extracts; Plants, Medicinal; Pruritus; Sesquiterpenes; Treatment Outcome | 2000 |
Anti-inflammatory activity of hamamelis distillate applied topically to the skin. Influence of vehicle and dose.
The anti-inflammatory activity of hamamelis distillate has been evaluated with respect to drug concentration (0.64 mg/2.56 mg hamamelis ketone/100 g) and the effect of the vehicle (O/W emulsion with/without phosphatidylcholine (PC) in an experimental study. The effects were compared with those of chamomile cream, hydrocortisone 1% cream and 4 base preparations. Erythema was induced by UV irradiation and cellophane tape stripping of the horny layer in 24 healthy subjects per test. Skin blanching was quantified by visual scoring and chromametry. Drug effects were compared with one another and with an untreated control area, as well as with any action due to the vehicle. UV-induced erythema at 24 h was suppressed by low dose hamamelis PC-cream and hydrocortisone cream. Hydrocortisone appeared superior to both hamamelis vehicles, hamamelis cream (without PC) and chamomile cream. The latter preparation was also less potent than hamamelis PC-cream. Erythema 4 to 8 h after the stripping of the horny layer was suppressed by hydrocortisone (P < or = 0.05). Inflammation was also less pronounced following low dose hamamelis PC-cream and chamomile cream. Hamamelis PC-cream, however, appeared less potent than hydrocortisone. In general, visual scoring was more discriminatory than chromametry. The results have demonstrated an anti-inflammatory activity of hamamelis distillate in a PC-containing vehicle. A fourfold increase of drug concentration, however, did not produce an increase in activity. Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Cellophane; Chamomile; Double-Blind Method; Emulsions; Erythema; Female; Flavonoids; Humans; Hydrocortisone; Male; Oils, Volatile; Ointments; Pharmaceutical Vehicles; Phosphatidylcholines; Plant Extracts; Plants, Medicinal; Ultraviolet Rays | 1993 |